0.9471
price up icon26.25%   0.1969
pre-market  Pre-mercato:  .96   0.0129   +1.36%
loading
Precedente Chiudi:
$0.7502
Aprire:
$0.7999
Volume 24 ore:
1.40M
Relative Volume:
4.58
Capitalizzazione di mercato:
$4.54M
Reddito:
-
Utile/perdita netta:
$-14.07M
Rapporto P/E:
-0.0677
EPS:
-13.99
Flusso di cassa netto:
$-12.56M
1 W Prestazione:
+23.85%
1M Prestazione:
+53.43%
6M Prestazione:
-37.28%
1 anno Prestazione:
-78.13%
Intervallo 1D:
Value
$0.7647
$0.9478
Intervallo di 1 settimana:
Value
$0.72
$0.9478
Portata 52W:
Value
$0.60
$4.65

Palisade Bio Inc Stock (PALI) Company Profile

Name
Nome
Palisade Bio Inc
Name
Telefono
(858) 704-4900
Name
Indirizzo
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Name
Dipendente
8
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PALI's Discussions on Twitter

Confronta PALI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PALI
Palisade Bio Inc
0.9471 3.82M 0 -14.07M -12.56M -13.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Palisade Bio Inc Borsa (PALI) Ultime notizie

pulisher
Jul 21, 2025

What drives Palisade Bio Inc. stock priceTriple returns potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about Palisade Bio Inc. stockFree Predictions - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is Palisade Bio Inc. a good long term investmentTriple-digit return opportunities - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

Why Palisade Bio Inc. stock attracts strong analyst attentionBreakout Confirmation Tool - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Palisade Bio Inc. stock performs during market volatility2x Return Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Palisade Bio Inc. stock price move sharplySteady Income Ideas - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Palisade Bio appoints to its Board of Directors - MSN

Jul 10, 2025
pulisher
Jul 09, 2025

Palisade Bio appoints Emil Chuang to board of directors By Investing.com - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors - Santé log

Jul 09, 2025
pulisher
Jul 09, 2025

Palisade Bio Appoints Emil Chuang as New Director - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

IBD Drug Development Veteran Joins Palisade Bio Board: 2 FDA Approvals Under His Belt - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

Palisade Bio (NASDAQ:PALI) Trading Down 1.8% – Time to Sell? - Defense World

Jul 09, 2025
pulisher
Jun 09, 2025

Ulcerative Colitis Drugs Market 2034: Clinical trials, EMA, PDMA, FDA Approvals, Medication, Statistics, Revenue, Therapies, Prevalence and Companies by DelveInsight - Barchart.com

Jun 09, 2025
pulisher
Jun 04, 2025

Transpire Bio licenses rights to Intragrand’s PDE4 inhibitor ITG-1052 - BioWorld MedTech

Jun 04, 2025
pulisher
Jun 03, 2025

GEN Restaurant Group, Inc. (NASDAQ:GENK) Shares Acquired by Northern Trust Corp - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Sells 72,453 Shares of Eni S.p.A. (NYSE:E) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

The Wharf (Holdings) Limited (OTCMKTS:WARFY) Short Interest Up 27.0% in May - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Sells 46,682 Shares of Brookfield Renewable Co. (NYSE:BEPC) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Invesco S&P SmallCap Health Care ETF (NASDAQ:PSCH) Shares Purchased by Ameriprise Financial Inc. - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Yankuang Energy Group Company Limited (OTCMKTS:YZCAY) Short Interest Up 25.0% in May - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BOE Varitronix Limited (OTCMKTS:VARXF) Short Interest Update - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

U.S. Global Jets ETF (NYSEARCA:JETS) Shares Sold by Ameriprise Financial Inc. - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Riverside Resources (OTCMKTS:RVSDF) Stock Price Down 9.3% – Should You Sell? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Clune & Associates LTD. Invests $7.30 Million in Apple Inc. (NASDAQ:AAPL) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

5,157 Shares in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Bought by Northern Trust Corp - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Raises Holdings in Key Tronic Co. (NASDAQ:KTCC) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Purchases New Position in Quantum Computing Inc. (NASDAQ:QUBT) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Cetera Investment Advisers Purchases Shares of 70,006 Palisade Bio, Inc. (NASDAQ:PALI) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Nuvation Bio’s (NUVB) “Market Outperform” Rating Reaffirmed at JMP Securities - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Boosts Stake in BlackRock California Municipal Income Trust (NYSE:BFZ) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Acquires New Shares in iShares 10-20 Year Treasury Bond ETF (NYSEARCA:TLH) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Torrid Holdings Inc. (NYSE:CURV) Shares Purchased by Bank of America Corp DE - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

TPI Composites, Inc. (NASDAQ:TPIC) Shares Acquired by Bank of America Corp DE - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Palisade Bio Reports Improved Quarterly Losses - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Increases Position in Community West Bancshares (NASDAQ:CWBC) - Defense World

Jun 02, 2025
pulisher
May 27, 2025

Palisade Bio (PALI) Reports Positive Phase 1 Results for PALI-21 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Palisade Bio reports positive Phase 1 results for new drug By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Topline Data From Phase 1 Studies Of PALI-2108 - Nasdaq

May 27, 2025
pulisher
May 27, 2025

Palatin Technologies (PALI) Teams Up with Key Managers for Inves - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Palisade Bio (PALI) Reports Positive Phase 1 Results for PALI-2108 | PALI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Palatin Technologies (PALI) Teams Up with Key Managers for Investment Strategy | PALI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Digital Ally, Inc. Sets Date to Discuss First Quarter 2025 Earnings Call Wednesday, May 28, 2025 at 11:15 a.m. Eastern Time - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Palisade Bio reports positive Phase 1 results for new drug - Investing.com

May 27, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Breakthrough in Crohn's Disease Treatment: New Drug PALI-2108 Achieves Perfect Safety Profile in Phase 1 Trial - Stock Titan

May 27, 2025
pulisher
May 25, 2025

Seneca Biopharma : Announces Update on Phase II Clinical Trial Underway in China for the Treatment of Ischemic Stroke - marketscreener.com

May 25, 2025
pulisher
May 23, 2025

Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga

May 23, 2025
pulisher
May 17, 2025

Palisade Bio Q2 EPS Lifted by Brookline Capital Management - Defense World

May 17, 2025
pulisher
May 15, 2025

Palisade Bio (NASDAQ:PALI) Earns “Buy” Rating from Brookline Capital Management - Defense World

May 15, 2025

Palisade Bio Inc Azioni (PALI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):